Professor Ishac Nazy held an interesting symposium durint the recent ISTH 2022 congress. He shared us his thought about ISTH proposal to standardize functional assays in the diagnosis of Heparin‐induced Thrombocytopenia.

Video: https://congressreport.eu/scientific-contents/interview:isth-proposal-standardize-functional-assays-diagnosis-heparininduced-thrombocytopenia

Professor Margareth C. Ozelo shared us his thought about a symposium held at the recent ISTH 2022, which topic was about general issues related to joint health for hemophilia patient.

Video: https://congressreport.eu/scientific-contents/interview:navigating-joint-health-journey-patients-hemophilia-how-can-you-make-lasting-impact

Professor Deborah Siegal chaired an interesting symposium during the ISTH 2022 congress in London, the topic was strategies for assessing and managing DOAC-related bleeding.

Video: https://congressreport.eu/scientific-contents/interview:strategies-assessing-and-managing-doac-related-bleeding

Professor Johnny Mahlangu shared with us a symposium that they organized during the ISTH 2022 congress. They examined approaches to standardisation and monitoring for Haemophilia Gene Therapy.

Video: https://congressreport.eu/scientific-contents/interview:approaches-standardisation-and-monitoring-haemophilia-gene-therapy-consistency-considerations-and-challenges

We asked Dr. Emma Leitinger about their work which was presented as a poster at the recent ISTH 2022 congress.

Video: https://congressreport.eu/scientific-contents/interview:comparison-between-full-dose-and-reduced-dose-enoxaparin-management-cancer-associated-venous-thromboembolism

We asked Professor Antonia Follenzi about their research data on the role of Factor VIII, what she presented on the recent ISTH 2022 congress in London.

Video: https://congressreport.eu/scientific-contents/interview:roles-fviii-endothelial-cell-biology-more-coagulation-factor

Professor Paolo Mulatero co-chaired a Meet the Expert session about the novelties diagnosis and management of primary aldosteronism at the recent ESH 2022.

Video: https://congressreport.eu/scientific-contents/interview:diagnosis-and-management-primary-aldosteronism

We asked Professor Michel Burnier about the adherence to antihypertensive treatment in patients with CKD, what he presented at the ESH Working Group on Hypertension and Kidney during the recent European Socity of Hypertension congress in Athens.

Video: https://congressreport.eu/scientific-contents/interview:adherence-antihypertensive-treatment-patients-ckd-barrier-optimal-renoprotection

We asked Professor Philip Haddad about anticoagulation treatment of patients with brain tumor. Professor Haddad presented a meta-analysis of the use of DOACs versus LMWH in this indication at the recent ISTH congress

Video: https://congressreport.eu/scientific-contents/interview:brain-cancers-and-risk-intracranial-hemorrhage-direct-oral-anticoagulants-versus-low-molecular-weight-heparin

Professor Gianfranco Parati took part in many interesting sessions during the recent European Society of Hypertension. We asked to share his insight on the novelties from ESH 2022 with the audience.

Video: https://congressreport.eu/scientific-contents/interview:special-forms-hypertension-optomized-prevention-and-hypertension-epidemiology-novelties-esh-2022